Cargando…
Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV
[Image: see text] HIV-infected cells persist for decades in patients administered with antiretroviral therapy (ART). Meanwhile, an alarming surge in drug-resistant HIV viruses has been occurring. Addressing these issues, we propose the application of photoimmunotherapy (PIT) against not only HIV Env...
Autores principales: | Sadraeian, Mohammad, da Cruz, Edgar Ferreira, Boyle, Ross W., Bahou, Calise, Chudasama, Vijay, Janini, Luiz Mário Ramos, Diaz, Ricardo Sobhie, Guimarães, Francisco E. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246456/ https://www.ncbi.nlm.nih.gov/pubmed/34235324 http://dx.doi.org/10.1021/acsomega.1c01721 |
Ejemplares similares
-
Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells
por: Sadraeian, Mohammad, et al.
Publicado: (2020) -
A Plug-and-Play Platform for the Formation of Trifunctional
Cysteine Bioconjugates that also Offers Control over Thiol Cleavability
por: Bahou, Calise, et al.
Publicado: (2021) -
Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
por: Bahou, Calise, et al.
Publicado: (2018) -
Pharmacophore Variants of the Macrocyclic Peptide Triazole Inactivator of HIV-1 Env
por: Gupta, Monisha, et al.
Publicado: (2023) -
Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation
por: Bahou, Calise, et al.
Publicado: (2022)